Glass Lewis ures Dong-A's foreign shareholders to vote against Kang-Korea Alcohol nominees

Published: 2007-10-23 07:00:00

Updated: 2007-10-23 07:00:00

Dong-A Pharmaceutical Co. announced on October 19 that Glass Lewis & Co, one of the world's leading independent providers of proxy voting recommendations and corporate governance advisory services, have recommended their clients vote against the election of Kang-Korea Alcohol nominees on the comp...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK